1983年于上海第二军医大学毕业后，师从国际著名肾脏病学家黎磊石院士，在南京军区总医院肾脏病研究所学习

1、黄芪对腹膜透析效能及腹膜间皮细胞与腹腔免疫功能的影响

2、骨髓基质干细胞共培养构建生物人工肾的应用及其机制研究

3、细胞共培养法构建生物人工肾小管的研究

4、葛根素拮抗糖基化终产物对腹膜透析相关腹膜损伤的作用及机制研究

5、丹参酮ⅡA干预腹膜透析中腹膜间皮细胞生物学行为改变的基础与临床研究

6、RAGE基因单核苷酸多态性对国人早期固有型高转运腹膜透析的预测作用研究

7、单孔微创腔镜辅助腹膜透析置管的应用

8、从小管损伤角度探讨局灶节段性肾小球硬化病变的机制研究

9、探讨局灶节段性肾小球硬化病变的机制研究

1、Protection of Tanshinone IIA to human peritoneal mesothelial cells (HPMC) through delaying cellular senescence induced by high glucose. Ren Fail.2012,34(1):88-94.

2、Clinical application of one-port laparoscopic placement of peritoneal dialysis catheters. Scand J Urol Nephrol. 2010 Nov;44(5):341-344

3、 Impacts of puerarin on Oxidative stress in CAPD Patients.Perit Dial Int 2009;29:49.

4、 Oxidizad high-density lipoprotein enhances inflammatory activiy in rat mesangial cells.Diabetes Metab Res ReV 2010,26(6):455-463.

5、 Improvement of cytokine response and survival time by bioartificial kidney in acute uremic pigs.Int J Atif Organs.2010,33(8):526-534.

6、 Tanshinone IIA Attenuates Peritoneal Fibrosis through Inhibition of Fibrogenic Growth Factors Expression in Peritoneum in a Peritoneal Dialysis Rat Model.Ren Fail.2011,33(3):355-362.